Pharmacoepidemiology and Prescription
Online First™Open AccessPharmacovigilance in children in Camagüey Province, Cuba
Z. Bárzaga Arencibia, A. López Leyva, Y. Mejías Peña, A. R. González Reyes and E. Fernández Manzano, et al.
Online First™, 7 February 2012
Pharmacodynamics
Online First™Open AccessSwitching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
Andreas Clemens, Joanne van Ryn, Regina Sennewald, Norio Yamamura and Joachim Stangier, et al.
Online First™, 18 January 2012
Clinical Trial
Online First™Open AccessEffect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers
G. Zadoyan, D. Rokitta, S. Klement, A. Dienel and R. Hoerr, et al.
Online First™, 21 December 2011
Pharmacogenetics
Online First™Open AccessLack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide
Violetta Dziedziejko, Mateusz Kurzawski, Krzysztof Safranow, Andrzej Ossowski and Jaroslaw Piatek, et al.
Online First™, 13 October 2011
Pharmacogenetics
Online First™Open AccessFeasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
J. J. Swen, T. van der Straaten, J. A. M. Wessels, M. L. Bouvy and E. E. W. Vlassak, et al.
Online First™, 7 October 2011
Pharmacoepidemiology and Prescription
Open AccessSystematic review of safety in paediatric drug trials published in 2007
Khairun Nain Bin Nor Aripin, Imti Choonara and Helen M. Sammons
2012, Volume 68, Number 2, Pages 189-194
Pharmacodynamics
Open AccessOptimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation
Yusuke Tanigawara, Kenji Nozawa and Hisatsugu Tsuda
2012, Volume 68, Number 1, Pages 39-53
Pharmacoepidemiology and Prescription
Open AccessDopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
Maurits E. L. Arbouw, Kris L. L. Movig, Henk-Jan Guchelaar, Cees Neef and Toine C. G. Egberts
2012, Volume 68, Number 1, Pages 83-88
Clinical Trial
Open AccessThe relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine
Junichi Azuma, Tomoko Hasunuma, Masanori Kubo, Masaya Miyatake and Toshiko Koue, et al.
2012, Volume 68, Number 1, Pages 29-37
Pharmacogenetics
Open AccessDo CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
Trine Naalsund Andreassen, Ingrid Eftedal, Pål Klepstad, Andrew Davies and Kristin Bjordal, et al.
2012, Volume 68, Number 1, Pages 55-64